Description
Fc Engineered Anti-Human RSV Antibody, CDC-Enhanced (Biobet-C428ZP) is a recombinant monoclonal RSV antibody against RSV. This product is a CDC enhanced antibody produced by our proprietary platform.
Indication
Respiratory Syncytial Virus (RSV) disease
Classification
Therapeutic antibody; biobetter
Cooperation Seeking
Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced rituximab. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
RSV
Indication
Respiratory Syncytial Virus (RSV) disease
Respiratory Syncytial Virus (RSV) disease
